Myeloid Growth Factors Revisited
This information was originally presented on September 20, 2014, at the NCCN 9th Annual Congress: Hematologic Malignancies™ held in New York, New York.
This activity is designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.
Following this activity, participants should be able to:
- Summarize the role and application of myeloid growth factors in the supportive care for patients with cancer
Jeffrey Crawford, MD
Duke Cancer Institute
- 0.50 Participation
- 0.40 Nurse
- 0.50 Pharmacist
- 0.50 Physician